Skip to main content
Premium Trial:

Request an Annual Quote

InDevR, Applied Microarrays Partner to Deliver Custom Array Offering

NEW YORK (GenomeWeb) – InDevR and Applied Microarrays said today that they will work together to offer custom microarrays, instruments, and reagents for multiplexed assays.

The new partnership will combine Tempe, Ariz.-based AMI's background in contract custom array manufacturing with InDevR's assay development expertise and two microarray imaging platforms. Boulder, Colo.-based InDevR offers Vidia, a fluorescence-based system for scanning multiplex array and 96-well plate formats as well as a colorimetric AmpliPhox scanner for lower-throughput applications.

AMI CEO Alastair Malcolm told BioArray News that the combination of the two firm's offerings should provide their clients with "lower cost and faster turnaround time than [platforms] available from the high-density microarray providers."

Going forward, Malcolm said that AMI and InDevR will co-market their products as part of the non-exclusive agreement. He also said that AMI should benefit from its relationship with InDevR by reaching more clients and taking part in more projects.

Financial terms of the partnership were not disclosed.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.